Hardware Podcasts

155 - FDA Compliance Programs, Program 7536.000: CDER vs. CDRH led Inspections, Mock PAI's, Supplier Management, and What is a Manufacturer? with Laurie Auerbach

Let's Combinate · 25 Sept 2024 · 25m

What this episode covers

Laurie Auerbach, President of Compliance Prodigies, LLC, explains FDA Compliance Program 7356.000, clarifying that contract manufacturers (CMOs) and component suppliers selling bundled solutions are legally defined as combination product manufacturers. She highlights common failures in mock Pre-Approval Inspections (PAIs), particularly the misconception that drug GMPs (21 CFR 211) and ICH Q10 fully satisfy device requirements under 21 CFR Part 4. Auerbach emphasizes that sponsors often fail to audit suppliers for device-specific elements like design control, risk management, and specific supplier controls, leading to critical gaps in quality agreements and inspection readiness.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
Compliance Prodigies, LLC
Also
FDA, Compliance Program 7356.000, 21 CFR Part 4, 21 CFR 211, 21 CFR 820, ICH Q10, QMSR

Related episodes from other shows

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 30m

    What are the Top Compliance Issues Plaguing Medical Device Manufacturers?

    Tom Rynkiewicz, VP of RA/QA at Raland Compliance Partners, joins host John Spear to discuss the top compliance issues plaguing medical device manufacturers, specifically CAPA, complaints, and design controls. Rynkiewicz argues that these recurring FDA observations stem from flawed internal audit practices that audit isolated quality system components rather than the entire system holistically. He highlights how human behavior and corporate KPIs, such as tracking CAPA turnaround times instead of effectiveness, prevent companies from achieving a true quality culture with zero complaints. The conversation emphasizes the need for system-level auditing and transparency to prepare for potential FDA shifts toward stricter Good Manufacturing Practices (GMP) inspections.

    Quality & yieldCertification & compliance
    7 chapters

  • Global Medical Device Podcast · 35m

    #467: Combination Product Compliance: PMOA, 21 CFR Part 4 & QMS Alignment

    Jim Fentress, Director of Regulatory Affairs at Galero (a Santa Group company), explains the regulatory complexities of combination products, focusing on how the Primary Mode of Action (PMOA) dictates FDA oversight. He details the challenges pharmaceutical companies face when integrating device Quality Management Systems (QMSR/ISO 13485) into their existing CGMP frameworks under 21 CFR Part 4. The discussion covers specific friction points like risk management alignment (AAMI TIR105 vs. ICH Q9), labeling classifications, and the critical need for transparent change control protocols between device manufacturers and pharma partners.

    Certification & complianceDesign for manufacturing & NPI
    8 chapters

  • Global Medical Device Podcast · 36m

    FDA is Expanding its Case for Quality Program... Should Your Company Participate?

    Mike Drues of Vascular Sciences and John Spear of Greenlight Guru discuss the FDA's expansion of the Case for Quality initiative, a pilot program involving the CMMI Institute and MDIC that shifts focus from mere compliance to true product quality. They analyze the benefits for participating companies, such as exemption from routine inspections and expedited PMA supplement reviews, while debating whether the program's inclusion of non-compliant companies constitutes helpful guidance or inappropriate micromanagement. The conversation highlights the tension between regulatory hurdles and the need for continuous improvement in medical device manufacturing.

    Certification & complianceQuality & yield
    7 chapters

  • Global Medical Device Podcast · 44m

    Most Common Problems Found During FDA Inspections in 2022

    Mike Drues, President of Vascular Sciences, analyzes the FDA's 2022 inspection data to identify the most common reasons for Form 483s, highlighting CAPA, design controls, and complaint handling as the top three issues. He argues that these problems persist because companies focus on ticking regulatory boxes rather than understanding the underlying intent, often failing to perform adequate root cause analysis or document their quality management systems effectively. Drues emphasizes that medical device professionals must move beyond minimum compliance to prevent recurring errors and ensure patient safety through proactive prevention and rigorous validation.

    Quality & yieldCertification & compliance
    7 chapters

  • Global Medical Device Podcast · 50m

    Preparing for Remote and On-Site Inspections and Audits

    Steven Niedelman and Eric Henry from King & Spalding’s FDA and Life Sciences practice discuss strategies for medical device companies to prepare for FDA inspections and audits, particularly in the context of resumed on-site and remote inspections. They emphasize the importance of systemic corrective actions for CAPA issues, preparing for pre-market and for-cause inspections, and conducting thorough mock audits to ensure staff readiness. The guests also advise firms that received QMS exemptions under Section 564A to begin remediation toward compliance with 21 CFR 820 and ISO 13485.

    Certification & complianceQuality & yield
    7 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.